MACCALLINI, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 6.085
EU - Europa 4.069
AS - Asia 3.802
Continente sconosciuto - Info sul continente non disponibili 618
SA - Sud America 392
AF - Africa 58
OC - Oceania 4
Totale 15.028
Nazione #
US - Stati Uniti d'America 5.897
SG - Singapore 1.434
CN - Cina 1.046
IT - Italia 983
IE - Irlanda 486
TR - Turchia 444
UA - Ucraina 427
SE - Svezia 424
RU - Federazione Russa 375
VN - Vietnam 333
BR - Brasile 316
GB - Regno Unito 315
FR - Francia 309
IN - India 267
DE - Germania 230
PL - Polonia 149
FI - Finlandia 120
CA - Canada 115
AT - Austria 69
BD - Bangladesh 55
HK - Hong Kong 50
ES - Italia 49
MX - Messico 32
JP - Giappone 31
CZ - Repubblica Ceca 25
NL - Olanda 23
BE - Belgio 22
LT - Lituania 20
ZA - Sudafrica 20
AR - Argentina 18
ID - Indonesia 17
PK - Pakistan 16
VE - Venezuela 15
KR - Corea 14
CO - Colombia 13
IQ - Iraq 12
JM - Giamaica 11
AE - Emirati Arabi Uniti 9
CL - Cile 9
EC - Ecuador 9
MY - Malesia 9
SA - Arabia Saudita 8
CR - Costa Rica 7
KE - Kenya 7
MA - Marocco 7
PH - Filippine 7
PT - Portogallo 7
TW - Taiwan 7
AL - Albania 5
CH - Svizzera 5
GR - Grecia 5
GT - Guatemala 5
IL - Israele 5
UZ - Uzbekistan 5
AU - Australia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EG - Egitto 4
ET - Etiopia 4
HN - Honduras 4
HR - Croazia 4
IR - Iran 4
JO - Giordania 4
NP - Nepal 4
PE - Perù 4
PY - Paraguay 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
DK - Danimarca 3
LB - Libano 3
SK - Slovacchia (Repubblica Slovacca) 3
YE - Yemen 3
AZ - Azerbaigian 2
BH - Bahrain 2
KZ - Kazakistan 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BM - Bermuda 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
LY - Libia 1
MM - Myanmar 1
Totale 14.404
Città #
Singapore 1.080
San Jose 683
Chandler 605
Jacksonville 511
Ashburn 489
Dublin 477
Izmir 282
Beijing 268
Dearborn 233
Dallas 232
Chieti 213
Southend 198
Princeton 194
Council Bluffs 177
Nanjing 150
Santa Clara 146
The Dalles 136
Los Angeles 131
Ann Arbor 120
Ho Chi Minh City 113
Kraków 108
Cambridge 103
Wilmington 96
New York 85
Hanoi 70
Nanchang 66
Pescara 65
Altamura 62
Vienna 56
Buffalo 55
Tongling 55
Munich 53
Moscow 49
Boardman 47
Hong Kong 43
Houston 41
São Paulo 41
Bosa 40
Warsaw 37
Atlanta 35
Orem 34
Shenyang 34
Teramo 33
Woodbridge 32
Hebei 31
Helsinki 31
Brooklyn 30
Jiaxing 30
Kocaeli 28
Redondo Beach 28
Tianjin 28
Columbus 27
Milan 27
Chennai 26
Denver 26
Kunming 26
Rome 26
Tokyo 26
Jinan 25
Montreal 24
Toronto 24
Brno 23
Hefei 23
Phoenix 23
Brussels 22
Washington 22
Changsha 21
Ottawa 21
Da Nang 20
London 20
Stockholm 20
Fairfield 19
Hangzhou 18
Ningbo 18
Bologna 17
Chicago 16
Poplar 16
Frankfurt am Main 15
Turku 15
Nuremberg 14
Haiphong 13
Johannesburg 13
Rio de Janeiro 13
Falls Church 12
Guangzhou 12
Mexico City 12
Norwalk 12
Ankara 11
Dong Ket 11
San Francisco 11
Seattle 11
Amsterdam 10
Biên Hòa 10
Como 10
New Delhi 10
Augusta 9
Manchester 9
Mumbai 9
Orange 9
Zhengzhou 9
Totale 8.820
Nome #
Valutazione biologica e computazionale di inibitori della Ossido Nitrico Sintasi 255
Anticancer Activity of Stilbene-Based Derivatives 199
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 196
Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid 194
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 192
Amidine N-sostituite come potenziali inibitori delle Ossido Nitrico Sintasi 183
Valutazione biologica dei derivati dell'acido clofibrico come potenziali ligandi PPARs 179
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 176
Titanium-Promoted Acylation of Sulfonamides to N-Acylsulfonamide PPAR Antagonists 175
Hemopressin peptides as modulators of the endocannabinoid system and their potential applications as therapeutic tools 175
Synthesis, biological activity, and docking studies of novel acetamidines as selective modulators of nitric oxide synthase 174
Recent developments of amidine-like compounds as selective NOS inhibitors 173
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 170
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 168
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation 168
Synthesis and biological evaluation of potential Nitric Oxide Synthase inhibitors 165
Benzothiazole-based N-(phenylsulfonyl)amides as a novel familyof PPARa antagonists 163
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro 163
Synthesis of benzothiazolyl-thioalkanoic acids and pharmacological evaluation on PPARa 162
Cytotoxic effect of a family of Peroxisome Proliferator-Activated Receptor antagonists in colorectal and pancreatic cancer cell lines 162
Determinazione della configurazione assoluta di acidi carbossilici a-sostituiti di interesse farmaceutico attraverso spettroscopia NMR 161
Asymmetric Synthesis of Arylpropionic Acids and Aryloxy Acids by Using Lactamides as Chiral Auxiliaries 160
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking 160
Enantiomeric separation of Gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector 158
Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives 158
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 154
Synthesis and biological evaluation of gemfibrozil chiral analogs as potential PPARa agonists 152
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 151
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 148
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 147
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 147
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors 147
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs 147
Synthesis and antiplatelet activity of clofibric acid analogues 145
Synthetic Strategies to Serine-Proline Chimeras: An Overview 144
Selective inhibition of inducible Nitric Oxide Synthase by derivatives of acetamidine 143
Synthesis, biological evaluation and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase 142
Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases 141
Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies 141
Amidine-Based Compounds Affecting L-Arginine Metabolism 139
Convergent Solution Phase and Solid Phase Synthesis for the Preparation of beta- Lactam antibiotic libraries. 138
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 138
Synthesis of naphthyl-, quinolin- and anthracenyl analogues of clofibric acid as PPARα agonists 138
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism 137
Synthesis and biological evaluation of new acetamidines as selective inhibitors of Nitric Oxide Synthases 136
Amidine-Based Bioactive Compounds for the Regulation of Arginine Metabolism 136
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 134
Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies 134
Novel aminobenzyl-acetamidine derivative modulate the differential regulation of NOSs in LPS induced inflammatory response: Role of PI3K/Akt pathway 134
Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome 133
Analoghi eterociclici dell’acido clofibrico: sintesi, attività antiaggregante piastrinica e separazione in elettroforesi capillare 131
Starting a new series of acetamidines as Nitric Oxide Sinthase inhibitors 131
Structural development studies of PPARs ligands based on tyrosine scaffold 131
Dynamic kinetic resolution of α-bromoesters containing lactamides as chiral auxiliaries 130
The excitation-contraction coupling on C2C12 skeletal muscle myotubes was modulated by NO-donor ester of gemfibrozil 130
Advancements in the Research of New Modulators of Nitric Oxide Synthases Activity 129
Synthesis and biological evaluation of novel acetamidines as nitric oxide inhibitors 128
N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase 128
null 128
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 127
Dual-PPAR agonists based on stilbene scaffold: synthesis and biological evaluation 127
Design, synthesis and biological activity of selective hCAs inhibitors based on 2-(benzylsulfinyl)benzoic acid scaffold 126
Selective Inhibition of iNOS by Benzyl- and Dibenzyl Derivatives of N-(3-Aminobenzyl)acetamidine. 126
Sintesi di esteri del gemfibrozil donatori di ossido nitrico 125
Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity 125
Synthesis of potential dual binding site acetylcholinesterase inhibitors through an efficient solid phase approach based on the Mitsunobu reaction 125
Targeting neuronal nitric oxide synthase as a valuable strategy for the therapy of neurological disorders 124
Platelet aggregation: synthesis and pharmacological evaluation of clofibric acid analogues 122
Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine on cellular line H2C9 121
Synthetic methodologies for the preparation of arginine-proline derivatives 120
New amidine-benzenesulfonamides as iNOS inhibitors for the therapy of the triple negative breast cancer 119
Synthesis and cytotoxicity evaluation of novel amide and sulfonimide PPARa antagonists 119
Design, synthesis and biological evaluation of aromatase inhibitors based on sulfonates and sulfonamides of resveratrol 118
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential 117
Novel Phenyldiazenyl Fibrate Analogues as PPAR Agonists: Design, Synthesis and Pharmacological Evaluation 114
Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors 114
Targeting iNOS As a Valuable Strategy for the Therapy of Glioma 113
Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors 113
Sintesi di derivati eterociclici dell’acido clofibrico a potenziale attività antiaggregante piastrinica 112
In vitro protective effects of resveratrol and stilbene alkanoic derivatives on induced oxidative stress on c2c12 and mcf7 cells 112
Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines 112
CAPE derivatives: Multifaceted agents for chronic wound healing 111
Azobenzene as Multi-Targeted Scaffold in Medicinal Chemistry 111
Methods to Evaluate the Activity of Nitric Oxide Synthase 111
Capillary electrophoretic enantioseparation of gemfibrozil analogues by use of TM-b-cyclodextrin as chiral selector 110
Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors 110
Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies 109
“Insight into diastereospecific solvolysis of peptidyl-b-lactams: combined kinetic and conformational studies” 109
N-substituted acetamidines as nitric oxide synthase inhibitors 108
Design, synthesis and biological evaluation of novel acetamidines as selective inducible nitric oxide synthase inhibitors 107
Reversed-phase high-performance liquid chromatography method with fluorescence detection to screen nitric oxide synthases inhibitors. 107
Choline Chloride-Based DES as Solvents/Catalysts/Chemical Donors in Pharmaceutical Synthesis 107
Fibrate-Based Analogues as PPARs Agonists: Synthesis and Structure–Activity Relationships 106
Acetamidine-Based iNOS Inhibitors as Molecular Tools to Counteract Inflammation in BV2 Microglial Cells 106
A novel life for antitumor combretastatins: Recent developments of hybrids, prodrugs, combination therapies, and antibody-drug conjugates 105
QSAR, QSPR and QSRR in terms of 3-D-MoRSE descriptors for in silico screening of clofibric acid analogues 105
Screening of NOS activity and selectivity of newly synthesized acetamidines using RP-HPLC 100
In vitro evaluation of a new selective iNOS inhibitor on normal rat astrocytes and C6 rat glioma cells 99
Insights into diastereospecific solvolysis of peptidyl-beta-lactams: combined kinetic and conformational studies 95
N-Acylsulfonylamides as a new class of PPARa antagonists 93
Totale 13.741
Categoria #
all - tutte 57.307
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.307


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022635 0 0 22 105 70 18 24 49 97 30 71 149
2022/20231.712 124 243 127 169 162 345 88 129 213 21 56 35
2023/2024791 56 26 73 21 48 250 192 10 3 30 8 74
2024/20252.063 92 394 348 46 37 95 116 124 176 94 269 272
2025/20264.617 354 150 411 600 538 263 808 306 477 377 222 111
2026/2027417 108 219 90 0 0 0 0 0 0 0 0 0
Totale 15.028